1,495
Views
37
CrossRef citations to date
0
Altmetric
Short Communications

Honey, polen, and propolis extracts show potent inhibitory activity against the zinc metalloenzyme carbonic anhydrase

, , , , &
Pages 440-444 | Received 08 Apr 2010, Accepted 21 Jun 2010, Published online: 05 Aug 2010

Abstract

Three different honey extracts from the endemic plant in the Black Sea region Rhododendron ponticum, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1), more precisely the human (h) isoforms hCA I and hCA II. Hexane, methanol, ethanol, and water solid-phase extractions (SPEs) showed inhibitory activity towards the two CA isozymes which were related to the total phenolic content. The highest inhibitory effects (0.036–0.039 mg/mL) were those of propolis methanolic extract. Among the three different samples investigated here, the aqueous extracts showed lower inhibitory effects compred to the organic solvent SPE extracts (in the range of 1.150– 5.144 mg/mL). The studied honey extracts constitute an interesting source of phenolic derivatives that might serve to identify lead compounds, targeting the physiologically relevant enzymes CA I and CA II.

Introduction

The carbonic anhydrases (CAs, EC 4.2.1.1) are ubiquitous zinc enzymes, present in prokaryotes and eukariotes, being encoded by five distinct, evolutionarily unrelated gene families: the α-CAs (present in vertebrates, Bacteria, algae, and cytoplasm of green plants), the β-CAs (predominantly found in Bacteria, algae and chloroplasts of both mono- as well as dicotyledons), the γ-CAs (mainly present in Archaea and some Bacteria), and the δ- and ζ-CAs, present in marine diatoms, respectivelyCitation1–8. In mammals, 16 different α-CA isozymes or CA-related proteins were described, with very different subcellular localization and tissue distribution. Basically, there are several cytosolic forms (CA I–III, CA VII), four membrane-bound isozymes (CA IV, CA IX, CA XII, and CA XIV), one mitochondrial form (CA V), as well as a secreted CA isozyme, CA VICitation1–8. These enzymes catalyze a very simple physiological reaction, the interconversion between carbon dioxide and the bicarbonate ion, and are thus involved in crucial physiological processes connected with respiration and transport of CO2/bicarbonate between metabolizing tissues and lungs, pH and CO2 homeostasis, electrolyte secretion in a variety of tissues/organs, biosynthetic reactions (such as gluconeogenesis, lipogenesis, and ureagenesis), bone resorption, calcification, tumorigenicity, and many other physiologic, or pathologic processesCitation1–8. Many of these mammalian (human) isozymes are important targets for the design of inhibitors with clinical applicationsCitation1.

Several classes of CA inhibitors (CAIs) were describe so far, such as the metal-complexing anions, the unsubstituted sulfonamides and their bioisosteres (sulfamates, sulfamides), the phenols and thiophenols, which generally bind to the Zn(II) ion of the enzyme either by substituting the non-protein zinc ligand to generate a tetrahedral adductCitation1–3 or by addition to the metal coordination sphereCitation1, generating trigonal-bipyramidal species. Phenols bind to the zinc-coordinated water molecule/hydroxide ion. At least 25 clinically used drugs (sulfonamides and sulfamates) have been reported to possess significant CA inhibitory properties, and they have applications as diuretics and anti-glaucoma drugs, but it has recently emerged that CAIs could have potential as novel anti-obesity, anti-cancer, and anti-infective drugsCitation1. Furthermore, recent studies suggest that CA activation may provide a novel therapy for Alzheimer’s diseaseCitation1.

Recently, we have described several natural products based CAIs, which evidenced diverse chemotypes than the sulfonamides and their bioisosteres, such as for example natural product phenolsCitation9,Citation10, the coumarinsCitation11,Citation12 and other such compounds. This led to a strong diversification of the chemotypes known to show strong activity as enzyme inhibitors and also to the discovery of a novel mechanism of inhibition of CAs with coumarins and structurally similar derivatives binding to the enzyme in a totally new manner, without interacting with the catalytically crucial metal ionCitation11–13. For example, the natural product coumarin 1a was shown to be hydrolyzed enzymatically by the esterase CA activity to the cis-2-hydroxycinnamic acid derivative 1b, which occludes the entrance to the enzyme active site, and behaves as a low nanomolar CAICitation11. The same is true for the simple coumarin 2a, but in that case the CAIs is the trans-2-hydroxycinnamic acid 2bCitation12. Another interesting CAIs recently identified is the diphenolic fungal metabolite 3, which showed low nanomolar inhibitory activity against some mitochondrial CA isoformsCitation9. Thus, natural products seem to be a valuable source of enzyme inhibitors targeting CAs, enzymes involved in many pathologic statesCitation1.

Honey, pollen, and propolis are highly valuable products of the domestic bee (Apis mellifera) The composition of these products is rather variable, and depends on many biogeographical conditions such as the plant types, climate, environmental conditions, and contribution of the beekeeperCitation14. These food products have been used in folk medicine since the early ages of human history, whereas more recently their role in the treatment of burns, gastrointestinal disorders, asthma, infected wounds, and skin ulcers has been also reinvestigatedCitation15–17. These food products have been reported to contain about 150–200 ppm compounds such as polyphenols (phenolic acids, flavonoids, and their derivatives), terpenes, steroids, amino acids, etc.Citation15,Citation18,Citation19. Many studies reported that propolis, pollen, and honey contain a variety of phenolic acid and flavonoids, possessing a wide range of biological effects including antioxidant, anti-bacterial, and anti-inflammatory activitiesCitation20–22.

Considering our interest in natural products as sources of novel inhibitors of metalloenzymes, and particularly of the CAs, in this study, we used three honeybee samples of rhododendron honey, pollen, and propolis which are known to have high phenolic compounds content for investigation as CAIsCitation19. The endemic to the Black Sea rhododendron species Rhododendron ponticum, gives a honey which is locally known as “mad” or wild honey, and is being produced only in the Black Sea regionCitation19. This honey contains grayanotoxins (formerly known as andromedotoxins, acetylandromedol, or rhodotoxins) which are polyhydroxylated cyclic diterpenes possessing structures 4Citation19,Citation23. Rhododendron ponticum leaves and flower nectar (including honey made from plant nectar) are sources of these toxinsCitation23. The symptoms of poisoning due to the consumption of large amounts of this honey include sudden severe hypotension, bradycardia, and vertigoesCitation23. There is an anecdotical mentioning of mad honey, from the classic helenistic period, by Xenophon, towards 410 BC (Anabasis). In the Black Sea mountains the soldiers hired by Cyrus the younger and led by Xenophon (when returning from their expedition against Artaxerxes II) who consumed mad honey fainted and stayed unconscious until the next day (Xenophon, Anabasis).

Propolis is a resinous natural substance which is used to protect hives from bacterial/fungal infections, being collected from plants and tree buds or seep from the tree bark. Ethanolic propolis extracts were used in antioxidant preprations, as throat spray, or as an ingredient in cosmetics and toothpaste, showing anti-bacterial, anti-viral, antioxidant, anti-cancer, and anti-inflammatory activitiesCitation24,Citation25.

Pollen constitutes the reproductive cells of plants. Bees consume pollen in their own diets and use it to feed larvae. Pollen is used as a dietary supplement for human diet and it is reported to be a source of phenolic compounds with a host of biological activitiesCitation22.

The aim of the study was to investigate the in vitro inhibitory effects of bee honey products including mad honey from R. ponticum, on human CA isoforms involved in crucial physiologic and pathologic processes, such as CA I and CA II. As far as we know, this is the first study investigating the inhibition of CAs with food-derived products.

Materials and methods

Reagents

Analytical grade solvents (methanol, ethanol, and hexane) were obtained from Merck Co. (Merck, Darmstadt, Germany). Buffers and other reagents were the highest purity grade, from Sigma-Aldrich (Milan, Italy). CA isozymes were recombinant ones, obtained as reported earlierCitation5,Citation9,Citation10. Honey was from R. ponticum flowers (mad honey) whereas the pollen and propolis were multiflower ones, commercially available samples from the Trabzon region, Black Sea, Turkey.

Samples and preparation of extracts

Propolis, pollen, and honey samples were supplied by chairmanship of Zonguldak, Türkiye Honey Agricultural Cooperative as the product of whole season of 2008. The crude samples were stored at +4°C in refrigerator. About 5 g of sample was weighed and added to 100 mL solvent (methanol, ethanol, hexane, and water). Then, each sample was continuously stirred with a shaker at room temperature for 24 h. The suspension was removed by centrifuged at 10,000g for 15 min. Then, the supernatant was concentrated in a rotary evaporator under reduced pressure and the residue resolved in a minimal volume of the same solvent and kept in 4°C until used. In addition honey, pollen, and propolis, 5 g each, were dissolved in 50 mL methanol and the mixture was periodically stirred and the supernatant was filtered twice with Whatman no.4 and filter papers, respectively. The filtrate was applied to a solid-phase extraction (SPE) column (Supelco-LC18, Milan, Italy). Elution of phenolic from the column was performed with methanol and concentrated in a rotary evaporator.

CA catalytic activity and inhibition

An Applied Photophysics stopped-flow instrument has been used for assaying the CA catalysed CO2 hydration activityCitation26. Phenol red (at a concentration of 0.2 mM) has been used as indicator, working at the absorbance maximum of 557 nm, with 20 mM Hepes (pH 7.5) as buffers, and 20 mM Na2SO4 (for maintaining constant the ionic strength), following the initial rates of the CA-catalyzed CO2 hydration reaction for a period of 10–100 sec. The CO2 concentrations ranged from 1.7 to 17 mM for the determination of the kinetic parameters and inhibition constants. For each sample, at least six traces of the initial 5–10% of the reaction have been used for determining the initial velocity. The uncatalyzed rates were determined in the same manner and subtracted from the total observed rates. Solutions of extracts (10 mM) were prepared in distilled-deionized water and dilutions up to 0.01 nM were done thereafter with distilled-deionized water. Inhibitory sample and enzyme solutions were preincubated together for 15 min at room temperature prior to assay, in order to allow for the formation of the enzyme-inhibitor complex. The IC50 reprsents the concentration of inhibitor producing a 50% decrease of the catalytic rate and were obtained by non-linear least-squares methods using PRISM 3, and represent the mean from at least three different determinations.

Determination of total phenolic content

The content of total polyphenols was estimated according to the Folin-Ciocalteu method using gallic acid as reference standardCitation19. According to this procedure, the extracted solution was previously diluted in the proportion of 1:10 (0.5 mL) and then mixed with 0.5 mL of 0.2 N Folin–Ciocalteau reagents and 1.5 mL of 2% Na2CO3. The absorbance was read at 760 nm after 2 h of incubation at room temperature. Total phenolic content was expressed as mg of gallic acid equivalents per g of extract, by using a Standard graph. Among three honey bee’s samples, all propolis extracts showed the highest inhibitory effects ranging from 0.05 to 2.25 mg/mL.

Statistical analyses

Results are presented as mean values of two replicates. Data were tested using SPSS for Windows Release 10 (SPSS Inc. Chicago, IL). Pearson correlation was used to reveal differences and relations. Significant differences were statistically considered at the level of p < 0.05 otherwise given.

Result and discussion

Honey, pollen, and propolis are biologically active food products, probably containing hundreds of diverse natural substancesCitation14,Citation15. These food products are rich in phenolic compoundsCitation14,Citation19, and are becoming increasingly popular because of their potential role in contributing to human health. The composition of such products is variable and depends on several factors. Many studies reported that they contain a variety of flavonoids and phenolic acids (both benzoic and cinnamic acid derivatives), possessing a wide range of biological effects including anti-bacterial, anti-inflammatory, anti-allergic, and anti-thrombotic activities which make honey and derived products interesting antioxidantsCitation14–20. As far as we know, such products have been never tested for their potential inhibitory activity against the CA family of enzymes.

Indeed, CAs are physiologically relevant enzymes since they are present in a multitude of isoforms in various tissues, being involved in pH regulation, secretion of electrolytes, diuresis, CO2 transport and metabolism (biosynthetic reactions such as gluconeogenesis, ureagenesis, lipid biosynthesis)Citation1–7. Therefore, CA has been a long established target for drug design, with several sulfonamides of the type RSO2NH2 being used clinically since 1956, when acetazolamide AAZ, the first of these was approved as a diuretic 1]. Sulfonamides are now widely used drugs for the treatment or prevention of a variety of diseases such as glaucoma, gastroduodenal ulcers, acid-base disequilibria and diverse neurological/neuromuscular disordersCitation1–7,Citation27–29.

We have prepared several different solvent extractions (hexane, methanol, ethanol, water, and methanolic SPE extracts) of mad honey from R. ponticum, pollen and propolis and measured their total phenolic contents (). It should be mentioned that normal multiflower honey does not show any CA inhibitory activity (data not shown). The highest phenolic substance was found in the propolis extracts. Especially, the SPE column extracts showed higher phenolic content than other preparations because of the SPE (C-18) column specific for phenolic compounds separation. It may be observed that in the honey samples the total polyphenol content was between 10.48 and 95.46 mg/g of sample, whereas for the pollen and propolis the amounts were rspectively of 50–235.5 mg/g sample and of 13.45–464.4 mg/g sample ().

Table 1.  Inhibitory effects of honey, pollen, and propolis extracts against hCA I and hCA II, from three different determinations.

We measured thereafter the inhibitory effects of these samples against purified CA isoforms hCA I and II, which are the physiologically most relevant such enzymesCitation1,Citation27–29. The inhibition results are expressed as IC50 (mg/mL), . The meaning of IC50 is the extract concentration which reduces the CA activity by 50%. Among all the investigated samples, it may be observed that the extraction method highly influenced the CA inhibitory activity against both isoforms. Thus, for honey, against hCA I the inhibition was in the range of 0.123–2.961 mg/mL, with the best inhibition being observed for the hexane extracts, and the worst one for the water extract. Against hCA II, the IC50 were in the range of 0.125–3.150 mg/mL, again with best inhibition being observed for the hexane extract and the worst one for the water extracts ().

For the pollen extracts, against hCA I, the IC50 were in the range of 0.260–2.72 mg/mL, whereas against hCA II they were in the range of 1.01–9.11 mg/mL. In this case the most inhibitory activity against both isoforms was observed for the SPE column extracts, followed by the hexane extract (against hCA I) and the water extract (against hCA II). Propolis showed the highest inhibitory effects against both CA isozymes (). Indeed, against hCA I the IC50 were in the range of 0.0368–2.25 mg/mL whereas against hCA II in the range of 0.039–1.15 mg/mL, respectively. The order of the inhibitory effects on hCA I and hCA II for the extracts was as follows: propolis > pollen > rhododendron honey samples (meaning the corresponding various extracts in diverse solvents). In all the samples, we obtained a good negative correlation (R = −0.58, p < 0.05) between total phenolic compounds and the CA inhibition (). However, the negative correlation was higher in propolis extracts (R = −0.87 to −0.88, p < 0.01) and pollen extracts (R = −0.56 and −0.90, p < 0.05) than for honey extracts. Although mad honey was not containing high amounts of phenolic compounds (), it showed a good inhibitory effects on CA I and CA II. Especially the hexane and methanolic extracts of mad honey exhibited a good inhibitory effect. The Pearson correlation analysis of also showed a good correlation between the phenolic compounds content of the investigated samples and the inhibition of hCA I and hCA II isozymes. It is thus probable that the inhibitory effects we report may be indeed due to such biologically active components as the polyphenolsCitation30 or the grayanotoxins.

Table 2.  The results of statistical analyses for correlation (R) between phenolic compounds content and inhibition of hCA I and hCA II isozymes.

Grayanotoxin species from mad honey samples can show inhibitory effects against the CA I and CA II isozymes, but this hypothesis warrants further studies. The grayanotoxins may inhibited CAs by various mechanisms of action, resembling the interaction of CAs with phenols or coumarins, among othersCitation10–12,Citation27–30. Work is in progress in our laboratories to elucidate the chemical nature of the compounds responsible for these inhibitory activty of honey and related food products against CAs.

Declaration of interest

This study was supported by Research Fund of Karadeniz Technical University (Project No: 2004, 111. 002.08). This research was also financed in part by a grant of the 6th Framework Programme of the European Union (DeZnIT project, to CTS). We thank also Mr. Selahattin GÜNEY for providing the authentic propolis samples. The authors do not declare any conflict of interest with the presented data from this article.

References

  • Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7:168–181.
  • Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003; 23:146–189.
  • Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opin Ther Pat 2006; 16:1627–1664.
  • Supuran CT. Carbonic anhydrases as drug targets. Curr Pharm Des 2008; 14:601–602.
  • Alterio V, Hilvo M, Di Fiore A, Supuran CT, Pan P, Parkkila S, Scaloni A, Pastorek J, Pastorekova S, Pedone C, Scozzafava A, Monti SM, De Simone G. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci USA 2009; 106:16233–16238.
  • Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004; 19:199–229.
  • Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010; 20:3467–3474.
  • Kivelä AJ, Kivelä J, Saarnio J, Parkkila S. Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours. World J Gastroenterol 2005; 11:155–163.
  • Davis RA, Innocenti A, Poulsen SA, Supuran CT. Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library. Bioorg Med Chem 2010; 18:14–18.
  • Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). Bioorg Med Chem Lett 2008; 18:1583–1587.
  • Maresca A, Temperini C, Vu H, Pham NB, Poulsen SA, Scozzafava A, Quinn RJ, Supuran CT. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009; 131:3057–3062.
  • Maresca A, Temperini C, Pochet L, Masereel B, Scozzafava A, Supuran CT. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 2010; 53:335–344.
  • Temperini C, Innocenti A, Scozzafava A, Parkkila S, Supuran CT. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors. J Med Chem 2010; 53:850–854.
  • Anklam E. A review of the analytical methods to determine the geographical and botanical origin of honey. Food Chem 1998; 63:549–562.
  • White JW. Composition of honey. In Honey: A Comprehensive Survey, Crane E., Ed., pp. 157–158, 1979, Heinemann, London.
  • Pietta PG, Gardana C, Pietta AM. Analytical methods for quality control of propolis. Fitoterapia 2002; 73 Suppl 1:S7–20.
  • Caravaca AM, Romero MG, Roman DA, Carretero AS, Gutiérrez AF. Advances in the analysis of phenolic compounds in products derived from bees. J Pharm Biomed Anal 2006; 41: 1220–1234
  • Ahn, R., Kumazawa, S., Usui, Y., Nakamura, J., Matsuka, M., Zhu, F. and Nakayama, T. Antioxidant activity and constituents of propolis collected in various areas of china. Food Chem., 2007, 101, 1383–1392.
  • Küçük M, Kolayli S, Karaoglu SA, Ulusoy E, Baltaci C. Biological activities of three different Turkish honey. Food Chem 2007; 100: 526–534
  • Marcucci MC, Ferreres F, García-Viguera C, Bankova VS, De Castro SL, Dantas AP, Valente PH, Paulino N. Phenolic compounds from Brazilian propolis with pharmacological activities. J Ethnopharmacol 2001; 74:105–112.
  • Pyrzynska K, Biesaga M. Analysis of phenolic acids and flavonoids in honey. Trends Anal Chem 2009; 28: 893–902.
  • LeBlanc BW, Davis OK, Boue S, DeLucca A, Deeby T. Antioxidant activity of Sonoran Desert bee pollen. Food Chem 2009; 115: 1299–1305.
  • Sütlüpinar N, Mat A, Satganoglu Y. Poisoning by toxic honey in Turkey. Arch Toxicol 1993; 67:148–150.
  • Santos FA, Bastos EM, Uzeda M, Carvalho MA, Farias LM, Moreira ES, Braga FC. Antibacterial activity of Brazilian propolis and fractions against oral anaerobic bacteria. J Ethnopharmacol 2002; 80:1–7.
  • Sarıkaya AO, Ulusoy E, Öztürk N, Tuncel M, Kolayli S. Antioxidant activity and phenolic acid content of chestnut honey and propolis. J Food Biochem 2009; 33: 470–481.
  • Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971; 246:2561–2573.
  • Hisar O, Beydemir S, Gülçin I, Küfrevioglu OI, Supuran CT. Effects of low molecular weight plasma inhibitors of rainbow trout (Oncorhynchus mykiss) on human erythrocyte carbonic anhydrase-II isozyme activity in vitro and rat erythrocytes in vivo. J Enzyme Inhib Med Chem 2005; 20:35–39.
  • Innocenti A, Hilvo M, Scozzafava A, Parkkila S, Supuran CT. Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols. Bioorg Med Chem Lett 2008; 18:3593–3596.
  • Sentürk M, Gülçin I, Dastan A, Küfrevioglu OI, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem 2009; 17:3207–3211.
  • Innocenti A, Beyza Oztürk Sarikaya S, Gülçin I, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem 2010; 18:2159–2164.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.